Trial Profile
Pivotal study of PT20 in dialysis dependent patients with hyperphosphataemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2015
Price :
$35
*
At a glance
- Drugs PT 20 (Primary)
- Indications Hyperphosphataemia
- Focus Registrational; Therapeutic Use
- 04 Mar 2015 As per a Phosphate Therapeutics media release, doses and regimen from other pivotal trial will be used in this trial. The data from these two trials will form the basis of NDAs for approval of PT20 in dialysis dependent patients with hyperphosphataemia
- 03 Mar 2015 New trial record